chemotherapy
Recognition for telechemotherapy pharmacists
An award-winning pharmacy team describes how they delivered chemotherapy to patients during the pandemic The WA Country Health Service (WACHS) TeleChemotherapy Pharmacy team has received national recognition from the Society of …
The week in review
It’s been a busy week for the Pharmacy Guild, as it battled a proposal to let patients get double quantities of some PBS medicines per script, and encouraged Aussies to …
SHPA defends pharmacists after vial sharing risk claims
SHPA has hit back at claims in a pharmaceutical publication about vial sharing in chemotherapy Earlier this week, pharmaceutical and life sciences publication PharmaDispatch published an article in which companies …
Two medicinal cannabis trials to start
Trials of cannabis-derived medicines are hoped to have answers for cancer pain and nausea Medlab Clinical Limited has received Human Research Ethics Committee approvals to begin human trials of two …
The week in review
We take a look back at the week in pharmacy Budget 2017, handed down by Treasurer Scott Morrison on Tuesday, contained more than a few measures affecting pharmacy, from the …
End in sight for chemo bungle
AHPRA is winding up investigations into five hospital pharmacists and four doctors involved in the SA chemotherapy under-dosing affair – with some facing regulatory action Over a period of six …
New chemo listing in indolent Non-Hodgkin’s Lymphoma
A cancer medicine that doubles progression free survival in people with indolent Non-Hodgkin’s Lymphoma and is less toxic than previous chemotherapy regimens will be added to the Pharmaceutical Benefits Scheme …
Deadly waiting game for prostate cancer drugs
Prostate cancer patients have to wait many years to get access to new cancer medicines compared to other countries such as the US. This is resulting in poorer quality of …
Action needed to cut prostate cancer deaths
Prostate cancer is the fourth most common cause of male deaths and more must be done improve survival rates, by detecting it early. Prostate cancer has the dubious distinction of being fourth most …